3Clayton AH, Thase ME, of bupropion extended release Haight BR,et al. Comparison and venlafaxine extended release for the treatment of depression: a double-blind, multi centre trial[J], gurop Neuropsychopharmacol, 2006,16 (4):316.
4Settle EC, Stahl SM, Batey SR, et al. Safety profile of sustained release bupropion in depression: results of three clinical trials[J]. Clin Ther, 1999,21 ( 3 ) : 454.
5Weihs KL, Houser TL, Batey SR, et al. Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression[J]. Biol Psychiatry, 2002,51 (9) :753.
二级参考文献21
1[1]Corcoran C,Wong ML,O'Keane V.Bupropion in the management of apathy[J].Psychopharmacol,2004,18 (1):133～135
2[2]Glod CA,Lynch A,Flynn E,et al.Open trial of bupropion SR in adolescent major depression[J].Child Adolesc Psychiatr-Nurs,2003,16(3):123～130
3[3]Weihs KL,Houser TL,Batey SR,et al.Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression[J].Biol Psychiatry,2002,51 (9):753～761
4[4]Weihs KL,Settle ECJr,Batey SR,et al.Bupropion sustained release versus paroxetine for the treatment of depression in the elderly[J].Clin Psychiatry,2000,61(3):196～202
6[6]Tomarken AJ,Dichter GS,Freid C,et al.Assessing the effects of bupropion SR on mood dimensions of depression[J].J Affect Disord,2004,78 (3):235 ～241
7[7]Jamerson BD,Krishnan KR,Roberts J,et al.Effect of bupropion SR on specific symptom clusters of depression:analysis of the 31-item Hamilton Rating Scale for depression[J].Psychopharmacol Bu11,2003,37(2):67～78
8[8]Croft H,Houser TL,Jamerson BD,et al.Effect on bodyweight of bupropion sustained-relese in patients with major depression treated for 52 weeks[J].Clin Ther,2002,24 (4):662～672
9[9]Tonstad S.Use of sustained-release bupropion in specific patient populations for smoking cessation[J].Drugs,2002,62 Suppl 2:37～43
10[10]Chengappa KN,Kambhampati RK,Perkins K,et al.Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants[J].Clin Psychiatry,2001,62(7):503～508
8Sackett DL, Clarke M, Oxman AD, et al. Cochrane Reviewers, Handbook 4. 2, In Renew Manager [M]. Versions 4. 2. England: The Cochrane Collaboration, 2002: 13.
9Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? [J]. Control Clin Trials, 1996, 17 (1): 1.
10N~euw strat en CE, Dolov ich LR. Bupropion versus selective serotonin reuptake inhibitors for treatment of depression [J]. Ann Pharmacother, 2001, 35 (12): 1608.
